A double-headed pro-drug that overcomes chloroquine resistance

Publisher： Elsevier

ISSN： 1471-4922

Source： Trends in Parasitology, Vol.18, Iss.3, 2002-03, pp. : 103-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Turning a chloroquine-resistance reverser into an antimalarial

By Egan T.J.

Trends in Parasitology, Vol. 18, Iss. 8, 2002-08 ,pp. : 344-344

Elsevier

Access to resources Recommend Favorite

Chloroquine: An Old Drug with New Perspective Against Giardiasis

Recent Patents on Anti-Infective Drug Discovery, Vol. 10, Iss. 2, 2015-08 ,pp. : 134-141

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular data on Plasmodium falciparum chloroquine and antifolate resistance: a public health tool

By Quaye I. Sibley C.H.

Trends in Parasitology, Vol. 18, Iss. 4, 2002-04 ,pp. : 184-186

Elsevier

Access to resources Recommend Favorite

Effects of chloroquine on viral infections: an old drug against today's diseases?

By Savarino A. Boelaert J.R. Cassone A. Majori G. Cauda R.

The Lancet Infectious Diseases, Vol. 3, Iss. 11, 2003-11 ,pp. : 722-727

Elsevier

Access to resources Recommend Favorite

Phase 1 Single Dose Studies to Optimize the Pharmacokinetics of DG17, a Novel HIV-Protease Inhibitor Pro-Drug, Using Sodium Bicarbonate and Ritonavir

Current HIV Research, Vol. 6, Iss. 3, 2008-05 ,pp. : 272-275

Bentham Science Publishers

Access to resources Recommend Favorite